background
pneumonia
lead
infecti
caus
child
mortal
global
mainli
afflict
develop
countri
prospect
observ
studi
aim
assess
microorgan
associ
pneumonia
children
age
year
develop
emerg
countri
method
multicent
casecontrol
studi
gabriel
global
approach
biolog
research
infecti
diseas
epidem
lowincom
countri
network
conduct
cambodia
china
haiti
india
site
madagascar
mali
mongolia
paraguay
case
hospit
children
radiolog
confirm
pneumonia
control
children
set
without
featur
suggest
pneumonia
nasopharyng
swab
collect
subject
virus
bacteria
identifi
reversetranscript
polymeras
chain
reaction
associ
microorgan
pneumonia
quantifi
calcul
adjust
popul
attribut
fraction
apaf
multivari
logist
regress
analysi
adjust
sex
age
time
period
pathogen
site
result
overal
case
control
analyz
microorgan
detect
respiratori
sampl
case
control
p
streptococcu
pneumonia
mycoplasma
pneumonia
human
metapneumoviru
rhinoviru
respiratori
syncyti
viru
rsv
parainfluenza
viru
influenza
viru
b
independ
associ
pneumonia
apaf
confid
interv
ci
pneumonia
ci
rsv
ci
rhinoviru
conclus
streptococcu
pneumonia
rsv
rhinoviru
may
major
microorgan
associ
pneumonia
infect
children
year
age
develop
emerg
countri
increas
pneumonia
vaccin
coverag
may
substanti
reduc
burden
pneumonia
among
children
develop
countri
cid
august
etiolog
pneumonia
children
treatment
infect
empir
due
insuffici
microbiolog
diagnos
least
primari
care
therefor
uptod
knowledg
pneumonia
etiolog
popul
would
help
target
empir
treatment
common
microbi
agent
multicentr
data
pneumonia
etiolog
develop
countri
ancient
streptococcu
pneumonia
haemophilu
influenza
type
b
hib
respiratori
syncyti
viru
rsv
frequent
describ
caus
pathogen
sever
epidemiolog
factor
human
immunodefici
viru
hiv
epidem
implement
vaccin
nation
levelparticularli
pneumococc
conjug
vaccin
pcv
hib
vaccin
secular
trend
may
modifi
distribut
caus
pathogen
addit
new
microorgan
mainli
virus
discov
moreov
diagnost
test
undergon
major
improv
sensit
therefor
multicent
casecontrol
studi
pneumonia
etiolog
asymptomat
control
warrant
main
object
prospect
multicent
casecontrol
studi
assess
microorgan
associ
pneumonia
children
year
old
develop
emerg
countri
popul
level
studi
protocol
inform
consent
statement
case
report
form
amend
studi
document
approv
local
institut
research
ethic
committe
supplementari
materi
databas
anonym
elig
patient
identifi
studi
clinician
site
consecut
hospit
patient
assess
elig
everi
season
least
year
pneumonia
case
fulfil
inclus
criteria
hospit
patient
age
month
present
cough
andor
dyspnea
tachypnea
defin
world
health
organ
breath
rate
cyclesminut
month
age
cyclesminut
month
age
first
symptom
appear
last
day
radiolog
confirm
primari
endpoint
pneumonia
follow
guidelin
inform
consent
statement
sign
parent
legal
guardian
primari
endpoint
pneumonia
confirm
least
medic
reader
studi
site
presenc
endpoint
consolid
chest
radiograph
pleural
effus
later
pleural
space
associ
pulmonari
parenchym
infiltr
effus
larg
enough
obscur
opac
wheez
initi
exclus
criterion
case
withdrawn
countri
creat
difficulti
enrol
patient
inclus
criteria
control
signssymptom
respiratori
illnessupp
respiratori
tract
infect
month
age
hospit
surgeri
attend
routin
outpati
appoint
mild
ill
routin
monitor
immun
etc
hospit
site
inform
consent
sign
parent
legal
guardian
origin
plan
includ
control
per
case
match
age
vs
month
date
admiss
month
goal
achiev
countri
overal
individu
match
frequencymatch
pool
analysi
perform
site
age
period
admiss
nasopharyng
swab
collect
use
flexibl
minitip
flock
swab
copan
diagnost
murrieta
california
individu
within
hour
admiss
process
similarli
site
nineteen
virus
bacteria
detect
use
reversetranscript
polymeras
chain
reaction
rtpcr
fasttrack
diagnost
respiratori
pathogen
plu
luxembourg
central
blind
qualiti
control
pcr
respiratori
valid
panel
provid
site
specimen
process
local
urin
whole
blood
pleural
effus
case
pleurisi
collect
case
within
hour
admiss
urin
sampl
subject
antibiot
test
whole
blood
subject
blood
count
blood
cultur
rtpcr
identifi
staphylococcu
aureu
pneumonia
hib
serum
creactiv
protein
crp
procalcitonin
pct
pleural
effus
process
respiratori
specimen
systemat
hiv
screen
hivinfect
children
known
seroposit
statu
admiss
pool
analysi
aim
includ
case
control
yield
power
detect
odd
ratio
or
exposur
control
regardless
exposur
preval
case
categor
variabl
report
number
percentag
compar
use
test
continu
variabl
report
mean
standard
deviat
sd
median
interquartil
rang
iqr
student
test
analysi
varianc
uncondit
regress
perform
partial
match
increas
power
gener
effici
multivari
logist
regress
use
quantifi
associ
microorgan
detect
nasopharyng
swab
pneumonia
risk
multivari
model
first
adjust
sex
age
categori
time
period
per
quarter
site
addit
adjust
microorgan
detect
nasopharyng
swab
stratifi
age
categori
use
separ
model
final
multivari
logist
model
undertaken
site
adjust
sex
age
categori
time
period
microorgan
adjust
popul
attribut
fraction
apaf
calcul
upper
respiratori
sampl
blood
rtpcr
data
avail
control
conceptu
apaf
estim
proport
reduct
individu
pathogen
absent
calcul
punafcc
function
stata
use
adjust
aor
multivari
model
adjust
pathogen
test
pool
analysi
siteand
agestratifi
analysi
among
pneumonia
case
posit
particular
pathogen
proport
diseas
attribut
background
rate
attribut
risk
fraction
fraction
pneumonia
case
attribut
pathogen
apaf
given
proport
case
posit
pathogen
multipli
attribut
risk
fraction
supplementari
materi
sensit
analys
assess
put
select
bia
multivari
logist
model
perform
calcul
apaf
exclud
site
individu
site
time
exclud
case
wheez
antibiot
detect
urin
test
p
consid
signific
statist
analysi
perform
use
stata
softwar
version
stata
corp
colleg
station
texa
miss
data
avoid
perform
complet
case
analysi
respiratori
sampl
sampl
characterist
miss
data
includ
describ
elig
children
patient
pneumonia
case
control
analyz
figur
proport
individu
exclud
reassess
inclus
criteria
rang
mongolia
paraguay
china
overal
children
male
mean
age
sd
month
nineteen
patient
hivinfect
tabl
describ
studi
popul
characterist
group
site
identifi
imbal
case
control
season
countri
therefor
multivari
analys
adjust
season
pneumonia
case
lower
weightforheight
z
score
p
vaccin
coverag
p
tabl
among
case
wheez
test
posit
urinari
antibiot
admiss
receiv
oxygen
nasopharyng
sampl
microorgan
detect
case
control
p
bacteria
case
control
p
viru
case
control
p
mix
viralbacteri
detect
case
control
p
case
differ
observ
respect
sex
age
categori
weightforheight
z
score
pcv
vaccin
rate
serum
pct
serum
crp
inhospit
mortal
accord
type
infect
detect
nasopharyng
swab
viral
bacteri
mix
viralbacteri
streptococcu
pneumonia
mycoplasma
pneumonia
human
metapneumoviru
hmpv
rhinoviru
rsv
parainfluenza
viru
influenza
viru
b
independ
associ
pneumonia
risk
tabl
supplementari
tabl
blood
rtpcr
case
posit
pneumonia
h
influenza
aureu
respect
eighti
case
posit
blood
cultur
possibl
attribut
bacteri
contamin
salmonella
speci
n
detect
blood
cultur
among
case
posit
blood
cultur
also
posit
speci
pneumonia
aureu
hib
respect
blood
pcr
pleural
sampl
obtain
case
microorgan
detect
pneumonia
n
aureu
n
adenoviru
n
bocaviru
n
case
posit
pneumonia
blood
rtpcr
posit
speci
respiratori
sampl
p
case
pcr
posit
pneumonia
pleural
respiratori
sampl
streptococcu
pneumonia
highest
apaf
ci
pool
analysi
valu
consist
regardless
age
tabl
supplementari
figur
rsv
secondhighest
apaf
invers
relationship
observ
rsv
pneumonia
age
rhinoviru
third
highest
apaf
independ
associ
pneumonia
younger
children
month
streptococcu
pneumonia
main
bacterium
associ
pneumonia
countri
except
cambodia
china
india
lucknow
site
figur
rsv
hmpv
also
signific
agent
pathogen
select
coupl
pneumonia
countri
apaf
valu
vari
mostli
within
individu
site
exclud
supplementari
figur
exclus
case
wheez
antibioticposit
urin
substanti
affect
estim
except
rsv
antibioticposit
case
exclud
supplementari
figur
prospect
multicent
casecontrol
studi
identifi
microorgan
associ
pneumonia
children
year
old
develop
emerg
countri
low
pcv
coverag
streptococcu
pneumonia
hmpv
rhinoviru
rsv
parainfluenza
viru
influenza
viru
b
mycoplasma
pneumonia
associ
pneumonia
risk
independ
sex
age
time
period
detect
pathogen
site
streptococcu
pneumonia
highest
apaf
detect
pneumonia
respiratori
sampl
case
indic
infect
colon
pneumococc
carriag
link
sever
risk
factor
includ
age
famili
size
model
account
age
site
sex
time
period
residu
confound
may
exist
pneumococci
commonli
recogn
primari
etiolog
pneumonia
pneumococcu
vaccin
dramat
decreas
incid
pediatr
pneumonia
caus
pneumonia
unit
state
recent
introduc
sever
develop
emerg
countri
countri
introduc
pcv
decemb
year
ago
countri
howev
countri
would
achiev
coverag
pcv
diphtheriatetanuspertussishepat
bpoliohib
vaccin
therefor
prevent
measur
pneumoniaemainli
vaccinationshould
prioriti
pcv
coverag
higher
control
studi
design
analyz
vaccin
effect
radiograph
criteria
pneumonia
defin
robust
endpoint
pcv
hib
vaccin
trial
may
bia
result
toward
bacteri
caus
viral
pneumonia
less
like
present
lobar
consolid
effus
howev
aim
focu
primarili
sever
pneumonia
requir
hospit
studi
site
low
pcv
vaccin
coverag
epidemiolog
may
vari
develop
countri
higher
vaccin
coverag
would
use
reassess
pneumonia
etiolog
year
evalu
impact
pcv
vaccin
rsv
main
viral
agent
associ
pneumonia
apaf
consist
previou
metaanalysi
show
rsv
caus
acut
lower
respiratori
infect
rsv
detect
decreas
age
accord
recent
find
set
differ
sourc
popul
case
definit
popul
rhinoviru
significantli
associ
pneumonia
high
detect
rate
control
rhinoviru
detect
american
children
hospit
communityacquir
pneumonia
debat
grow
evid
suggest
causal
role
rhinoviru
pneumonia
etiolog
human
metapneumoviru
may
also
import
describ
common
respiratori
pathogen
children
particularli
year
age
account
pediatr
acut
respiratori
infect
hospit
though
frequent
describ
agent
haemophilu
influenza
significantli
associ
pneumonia
high
hib
vaccin
coverag
could
explain
find
apaf
wide
employ
chronic
diseas
rare
infecti
diseas
base
paramet
preval
test
posit
among
case
odd
ratio
interpret
infecti
diseas
epidemiolog
less
demonstr
addit
pneumonia
investig
includ
control
group
account
carriag
preval
imperfect
test
thu
detect
sever
microorgan
nasopharyng
sampl
confirm
caus
role
blood
rtpcr
result
includ
apaf
estim
prevent
inform
bia
upper
respiratori
samplesalthough
specif
enough
diagnos
etiolog
individu
level
sampl
distant
diseas
sitemay
help
infer
figur
five
lead
microorgan
associ
pneumonia
children
studi
site
base
adjust
popul
attribut
fraction
apaf
respiratori
sampl
multivari
logist
regress
adjust
sex
age
categori
month
time
period
per
quarter
presenc
pathogen
microorgan
highest
apaf
fraction
per
site
shown
confid
interv
abbrevi
apaf
adjust
popul
attribut
fraction
ci
confid
interv
hmpv
human
metapneumoviru
piv
parainfluenza
viru
rsv
respiratori
syncyti
viru
